Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
NexgenRx ( (TSE:NXG) ) has issued an update.
NexgenRx has reported a strong financial performance for the first quarter of 2025, with a revenue increase of $342,604, marking an 8.14% growth compared to the previous year. The company’s EBITDA also saw a positive rise, and its cash position remains robust, indicating a solid operational footing. This growth is largely driven by organic expansion among existing clients and the introduction of a new client from their sales pipeline. NexgenRx is enhancing its iBenefits NexAdmin platform to improve user experience and continues to expand its network of healthcare providers using its secure web-portal, theclaimsXchange.com.
More about NexgenRx
NexgenRx is Canada’s only independent full-service Third-Party Administrator and Technology Solutions Provider, offering proprietary full front-end, eligibility, enrolment, hour bank, and mobile access capabilities. The company provides state-of-the-art claims adjudication and full provider network coverage, allowing Plan Sponsors to access sophisticated administration and health benefit technology applications in a cost-effective SaaS model.
Average Trading Volume: 13,994
Technical Sentiment Signal: Strong Buy
Current Market Cap: C$20.27M
See more insights into NXG stock on TipRanks’ Stock Analysis page.